United States · Platforms & data · Benzinga
With Dupixent's Patent Clock Ticking, Sanofi Circles Insmed

Detailed summary
Insmed Inc. (NASDAQ:INSM) stock surged Thursday following a report that French pharmaceutical giant Sanofi SA (NASDAQ:SNY) is exploring a potential acquisition of the respiratory…
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.benzinga.com)




